Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
ScreenPoint develops Deep Learning and image analysis technology for automated reading of mammograms.
PEPSCOPE aims to make protein kinase inhibitors better therapeutics by providing unique insights in their functioning.
GATT Technologies is a medical device company.
MIMETAS develops organ-on-a-chip tissue- and disease models for better, more reliable, and tailored medicines.
SuperBuddy is an online marketplace that enables its users to shop for groceries.
OostNL has invested in 77 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OostNL's top investment sectors include Medical, Biotechnology, Health Care, Analytics, Artificial Intelligence (AI). The firm invests across 14 different industry categories.
Among tracked funding rounds, ScreenPoint Medical received $28.0M in a Series C round. OostNL's total known invested capital is $476.4M.
OostNL's average investment size is $7.8M across its portfolio of 77 companies.
Recent OostNL portfolio additions include ScreenPoint Medical, Pepscope, GATT Technologies. These companies were founded in 2020 or later.